Emerging in the landscape of obesity therapy, retatrutide represents a unique method. Unlike many current medications, retatrutide functions as a dual agonist, simultaneously targeting both glucagon-like peptide-1 https://tasneemyhqw373512.blogkoo.com/the-novel-retatrutide-this-glp-gip-receptor-agonist-57972241